Back to LLY
Eurizon Capital SGR S.p.A. → LLY
Eurizon Capital SGR S.p.A. LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
4
Latest value
$485.6M
Q3 2026
Peak value
$568.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $568.8M |
| Q1 2026 | $403M |
| Q2 2026 | $517.3M |
| Q3 2026 | $485.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $485.6M | 417.7K | — | — |
| Q2 2026 | $517.3M | 429.1K | — | — |
| Q1 2026 | $403M | 441.2K | — | — |
| Q4 2025 | $568.8M | 528.9K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B